recent
sever
line
evid
demonstr
new
strain
coronavirus
sarscov
sever
acut
respiratori
syndromeassoci
coronaviru
pathogen
sar
within
short
period
sarscov
decod
complet
provid
fundament
basi
understand
pathogenesi
develop
effect
diagnost
therapeut
approach
howev
although
initi
sar
outbreak
end
peopl
still
quit
limit
knowledg
infecti
diseas
worri
recurr
sar
winter
express
medic
profession
diagnos
case
earli
stage
infect
major
concern
develop
sensit
assay
detect
dilut
viru
bodi
fluid
must
first
address
question
biolog
role
sarscov
structur
protein
play
strength
immunorespons
caus
protein
coronavir
structur
protein
n
protein
abund
throughout
infect
mrna
protein
level
compar
mrna
level
structur
gene
mrna
n
protein
express
three
ten
time
higher
postinfect
n
protein
high
composit
polar
amino
acid
residu
display
hydrophil
immunogen
exampl
murin
coronaviru
mcv
ref
turkey
coronaviru
tcv
ref
infecti
bronchiti
viru
ibv
ref
contrast
sarscov
structur
protein
contain
multipl
site
glycosyl
infect
may
caus
differ
immunorespons
n
protein
free
glycosyl
site
chang
immunolog
characterist
even
express
prokaryot
system
importantli
sarscov
n
protein
highli
conserv
almost
complet
ident
among
variou
strain
sequenc
far
featur
make
n
protein
use
groupspecif
serolog
assay
exampl
n
gene
ibv
express
bacteria
histidin
tag
nterminu
express
ibv
n
protein
use
antigen
develop
assay
detect
ibvspecif
antibodi
collisson
et
al
found
antigen
could
success
appli
diagnos
ibv
virus
differ
chicken
strain
util
baculoviru
express
system
tcv
n
protein
express
appli
specif
serolog
test
detect
tcv
antibodi
turkey
high
degre
concord
observ
elisa
indirect
fluoresc
antibodi
ifa
test
specif
therefor
studi
immunogen
properti
n
protein
may
form
basi
develop
immunodetect
assay
sar
also
formul
strategi
futur
vaccin
develop
diseas
present
studi
undertaken
explor
epitop
site
locat
sarscov
n
protein
gener
three
differ
length
n
protein
fragment
synthes
nine
peptid
deriv
n
protein
observ
recombin
protein
could
crossreact
antibodi
sar
sera
defin
antigen
site
n
protein
screen
synthes
peptid
sar
sera
use
western
blot
well
elisa
data
obtain
immunoassay
demonstr
epitop
site
within
cterminu
n
protein
amplifi
n
gene
fragment
use
cdna
reversetranscript
sarscov
mrna
templat
three
pair
primer
nfull
primer
pcr
reaction
shown
figur
size
pcr
product
coincid
well
theoret
estim
base
upon
genom
sequenc
kb
bp
bp
nfull
respect
sinc
primer
contain
addit
bamh
site
end
end
restrict
enzym
use
complet
digest
pcr
product
vector
digest
harvest
n
gene
fragment
ligat
linear
form
express
vector
figur
digest
vector
bamh
gener
three
dna
fragment
differ
molecular
weight
ident
pcr
product
indic
n
gene
fragment
insert
correctli
final
insert
confirm
dna
sequenc
data
shown
three
express
vector
transform
strain
protein
express
induc
iptg
interestingli
abl
produc
recombin
protein
even
without
induc
iptg
wherea
gener
protein
presenc
iptg
accord
hydrophob
analysi
n
protein
contain
sever
hydrophil
region
span
whole
n
protein
figur
thu
recombin
protein
expect
highli
solubl
contrari
three
recombin
protein
express
mainli
form
inclus
bodi
releas
limit
solubl
form
cytoplasm
recombin
could
purifi
directli
solubl
fraction
obtain
high
protein
yield
bacteri
pellet
treat
urea
follow
strong
probe
sonic
denatur
protein
retain
affin
henc
ninta
column
effect
appli
purif
recombin
shown
figur
high
puriti
protein
three
n
recombin
obtain
one
step
affin
chromatographi
lysat
infect
sarscov
test
western
blot
sar
sera
primari
antibodi
obviou
immunoprecipit
band
appear
around
kda
figur
close
molecular
weight
n
protein
base
upon
theoret
estim
experi
repeat
eleven
sera
sar
patient
give
consist
result
major
immunoreact
band
locat
kda
data
shown
check
immunoreact
recombin
n
protein
examin
western
blot
use
sera
sar
patient
figur
depict
three
n
recombin
strong
immunorespons
sar
sera
impress
size
nfull
protein
almost
ident
immunoposit
band
found
lysat
thu
evid
support
conclus
n
protein
express
cell
infect
sarscov
antigen
protein
anoth
potenti
import
phenomenon
immunoreact
intens
three
recombin
protein
quit
similar
nfull
protein
contain
whole
amino
acid
sequenc
n
protein
howev
two
recombin
truncat
n
protein
protein
amino
acid
cterminu
n
protein
wherea
protein
lack
amino
acid
nterminu
n
protein
contain
amino
acid
cterminu
henc
n
recombin
share
cterminu
distinguish
length
nterminu
sinc
similar
immunoreact
observ
three
n
recombin
may
share
similar
epitop
site
possibl
within
amino
acid
cterminu
share
three
recombin
n
protein
truncat
nterminu
seem
lose
immunorespons
sar
sera
indic
antigen
nterminu
n
protein
might
much
weaker
cterminu
hypothesi
support
elisa
experi
number
sar
sera
test
elisa
examin
immunoreact
n
recombin
three
n
protein
display
similar
posit
elisa
reactiv
data
shown
establish
three
n
recombin
share
amino
acid
n
protein
cterminu
share
similar
immunorespons
sar
sera
next
question
address
precis
local
epitop
site
within
region
basi
hydropathi
plot
nine
peptid
locat
region
select
synthes
synthes
peptid
screen
sar
sera
case
elisa
lysat
infect
cell
use
posit
control
elisa
reactiv
peptid
show
compar
elisa
reactiv
control
would
consid
immunoreact
n
fragment
tabl
summar
elisa
data
screen
nine
peptid
p
valu
import
indic
whether
signific
differ
elisa
reactiv
synthes
peptid
sarscov
antigen
two
peptid
compar
immunoreact
lysat
posit
detect
rate
respect
thu
epitop
site
cterminu
n
protein
like
locat
codon
sinc
antibodi
sera
sar
patient
recogn
viral
protein
synthes
peptid
inde
mimic
epitop
site
viru
elicit
immunorespons
neutral
immunoreact
elisa
peptid
compar
antigen
among
nine
synthes
peptid
henc
deduc
good
competitor
sarscov
viru
antibodi
bind
exist
epitop
site
prior
elisa
determin
peptid
incub
without
sar
serum
min
respect
ad
microtit
plate
coat
extract
protein
sarscov
predict
elisa
reactiv
attenu
increas
peptid
concentr
sar
sera
figur
furthermor
competit
experi
conduct
western
blot
pvdf
polyvinyliden
fluorid
membran
transblot
three
recombin
n
protein
incub
sar
serum
contain
peptid
compar
immunorespons
show
figur
crossreact
recombin
sar
antibodi
significantli
curtail
indic
peptid
inhibit
recognit
sarscov
antibodi
figur
peptid
therefor
confirm
epitop
site
exist
sarscov
well
three
recombin
protein
antigen
n
protein
coronaviru
famili
extens
studi
usual
n
protein
contain
multipl
epitop
site
howev
commonli
epitop
site
cterminu
instanc
epitop
site
tgev
transmiss
gastroenter
viru
mhv
mous
hepat
viru
ibv
locat
around
codon
ctermini
respect
similar
coronavirus
present
studi
confirm
antigen
site
locat
cterminu
sarscov
figur
hydropathi
plot
sarscov
n
protein
lot
region
protein
low
hydrophob
score
cterminu
specif
strong
hydrophil
two
major
forc
chargecharg
interact
hydrogen
bond
caus
hydrophil
hypothes
crucial
format
epitop
site
peptid
locat
hydrophil
region
cterminu
contain
high
content
polar
amino
acid
biophys
paramet
correl
well
valu
elisa
reactiv
well
intens
western
blot
two
peptid
use
antigen
find
thu
support
theori
hydrophil
peptid
charg
import
determin
immunoact
site
sarscov
n
protein
describ
n
protein
sarscov
hydrophil
chargeabl
major
function
n
protein
coronavirus
stabil
genom
rna
form
helic
ribonucleocapsid
rnp
locat
viral
core
highli
stabl
condit
high
ionic
strength
highli
resist
action
rnase
locat
viru
n
protein
rare
glycosyl
infect
cell
henc
recombin
protein
solubl
express
bacteri
system
contrari
three
recombin
n
protein
express
solubl
form
mainli
gener
inclus
bodi
although
number
approch
taken
improv
solubl
recombin
alter
express
temperatur
decreas
induc
concentr
format
inclus
found
strain
consist
misfold
mechan
believ
behind
phenomenon
moreov
phenomenon
may
explain
role
n
protein
viru
n
protein
viral
genom
rna
interact
reciproc
stabil
bacteri
express
system
precipit
n
protein
could
result
absenc
rna
molecul
serolog
assay
wide
use
diagnosi
viru
infect
host
low
cost
fast
speed
high
accuraci
urgent
situat
common
way
serolog
assay
use
viral
lysat
antigen
nevertheless
use
viral
lysat
bring
drawback
instanc
peopl
prepar
sarscov
lysat
risk
infect
instead
viral
lysat
recombin
protein
use
avoid
problem
howev
gener
proper
antigen
specif
sarscov
tough
challeng
major
problem
discov
high
antigen
fragment
viral
protein
studi
specif
epitop
site
identifi
significantli
recombin
protein
synthes
peptid
confirm
strong
immunorespons
patient
sera
determin
either
elisa
western
blot
screen
total
sar
patient
normal
sampl
antigen
either
recombin
peptid
shown
potenti
applic
clinic
diagnosi
neg
detect
rate
posit
detect
rate
therefor
inform
provid
report
regard
epitop
site
n
protein
potenti
benefit
develop
diagnost
techniqu
e
coli
strain
purchas
beij
dingguo
corpor
beij
china
primer
synthes
shanghai
ding
corpor
shanghai
china
bacteri
protein
express
vector
purchas
novagen
darmstadt
germani
restrict
enzym
nitroblu
tetrazolium
chlorid
nbt
indolyphosph
ptoluidin
salt
bcip
obtain
promega
madison
usa
taq
dna
polymeras
relat
pcr
reagent
invitrogen
carlsbad
usa
ninta
resin
purchas
qiagen
hilden
germani
antibodi
antihuman
igg
conjug
alkalin
phosphatas
purchas
beij
zhongshan
compani
beij
china
sera
sar
patient
hospit
beij
control
sera
obtain
healthi
volunt
clinic
diagnost
criteria
sar
follow
clinic
descript
sar
releas
http
wwwwhointcsrsarsguidelinesen
sarscov
strain
use
studi
cultur
microb
epidem
institut
academi
militari
medic
scienc
genom
sequenc
beij
genom
institut
bgi
n
protein
fragment
design
base
upon
genom
sequenc
sarscov
propag
cell
describ
microb
epidem
institut
academi
militari
medic
scienc
viral
propag
cell
harvest
place
h
inactiv
viru
infect
cell
cultur
medium
concentr
polyethylen
glycol
peg
follow
cell
lysi
protein
denatur
urea
cell
lysat
sonic
probe
sonic
centrifug
g
remov
insolubl
debri
supernat
use
western
blot
elisa
determin
amino
acid
sequenc
n
protein
download
protscal
program
swiss
institut
bioinformat
sib
analyz
physic
characterist
protein
hydrophil
hydrophob
access
residu
buri
residu
molecular
weight
pi
valu
total
nine
peptid
rang
size
amino
acid
residu
select
synthesi
peptid
synthes
commerci
chines
peptid
corpor
hangzhou
china
synthes
peptid
character
hplc
mass
spectrometri
viral
genom
rna
prepar
use
trizol
reagent
invitrogen
firststrand
cdna
synthesi
carri
superscript
system
describ
product
manual
invitrogen
primer
pcr
amplif
synthes
shanghai
ding
co
full
length
n
gene
amplifi
pcr
use
primer
pair
primer
ataagaatgcggccgcttatgcctgagttgaa
restrict
site
primer
cgggatccatgtctgataatggacccca
bamh
site
gener
fragment
pair
primer
design
follow
primer
ataagaatgcggccgcttatgcctgagttgaa
site
primer
cgggatcccctcgccaaaaacgtact
bamh
site
primer
aagaatgcggccgcttatgcctgagttgaa
site
primer
cgggatccgctaacaaagaaggcatcgta
bamh
site
restrict
digest
digest
fragment
contain
n
gene
ligat
linear
vector
three
transform
stain
contain
express
vector
inocul
ml
lb
broth
contain
kanamycin
shake
cultur
grew
optic
densiti
od
nm
iptg
ad
final
concentr
mm
bacteria
incub
addit
h
follow
centrifug
g
min
get
bacteri
pellet
pellet
resuspend
ml
bind
buffer
contain
mm
trishcl
ph
mm
nacl
mm
imidazol
lyse
sonic
min
result
lysat
centrifug
g
min
supernat
pellet
examin
sdspage
sdspolyacrylamid
gel
electrophoresi
western
blot
check
solubl
express
protein
inclus
form
bacteri
pellet
dissolv
bind
buffer
contain
urea
recombin
protein
purifi
affin
chromatographi
ninta
qiagen
linear
elut
imidazol
recombin
protein
separ
sdspage
transfer
onto
pvdf
membran
membran
block
bsa
tri
mm
nacl
mm
ph
ttb
incub
sera
sar
patient
primari
antibodi
antihuman
igg
conjug
alkalin
phosphatas
use
second
antibodi
immunoprecipit
band
develop
use
substrat
mixtur
nbt
bcip
elisa
test
carri
accord
convent
protocol
brief
purifi
fusion
protein
mix
sampl
dilut
buffer
embed
elisa
plate
incub
min
well
wash
five
time
wash
buffer
incub
sera
sar
patient
normal
control
well
wash
incub
peroxidaseconjug
goat
antihuman
igg
min
final
well
wash
pb
contain
peroxidas
reaction
visual
use
opheylenediamin
solut
substrat
min
incub
reaction
stop
ad
sulphur
acid
od
nm
refer
wavelength
nm
measur
use
automat
elisa
plate
reader
multiskan
micropl
photomet
finland
